Phreesia, Inc.
NYSE•PHR
CEO: Mr. Chaim Indig
セクター: Healthcare
業種: Medical - Healthcare Information Services
上場日: 2019-07-18
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware.
連絡先情報
1521 Concord Pike, Suite 301 PMB 221, Wilmington, DE, 19803, United States
888-654-7473
時価総額
$551.73M
PER (TTM)
235.2
25.2
配当利回り
--
52週高値
$32.76
52週安値
$7.77
52週レンジ
順位59Top 87.6%
2.2
F-Score
改良版 Piotroski 分析
8年ファンダメンタル
弱い • 2.2 / 9 ポイント
スコアレンジ (0-9)
8-9: 価値が優れている
6-7: 基礎体質が強い
4-5: 全体的に堅調
0-3: パフォーマンスが弱い
データ期間: 2018-2025
財務ダッシュボード
Q4 2026 データ
売上高
$127.07M+0.00%
直近4四半期の推移
EPS
$0.02+0.00%
直近4四半期の推移
フリーCF
$31.10M+0.00%
直近4四半期の推移
2026 Q3 決算ハイライト
主なハイライト
Revenue Growth Strong Total revenue reached $120.3M for the quarter, marking a 13% increase from $106.8M last year.
Profitability Turnaround Achieved Quarterly net income was $4.3M, reversing the $14.4M net loss reported in the prior year period.
Adjusted EBITDA Surges Nine-month Adjusted EBITDA grew substantially to $72.1M, up from $20.4M in the comparable prior period.
Cash Flow Strengthens Free cash flow for the quarter was $8.8M, significantly higher than $1.6M generated in the prior year.
リスク要因
Competition Pressures Margins Highly competitive industry requires effective competition against EHR/PM systems; results may be harmed.
Client Retention Uncertainty Reliance on existing clients; contracts may not renew or may renew at lower fee levels impacting revenue.
Cybersecurity and Data Risks Collecting sensitive patient data exposes the company to cyber-attacks, legal penalties, and reputational damage.
Growth Management Challenges Variable sales cycles and implementation delays risk revenue recognition timing and future operating fluctuations.
見通し
AccessOne Integration Focus Management expects to integrate AccessOne acquisition, realizing anticipated operational synergies and benefits post-closing.
Financing Strategy Evolving Ability to satisfy $110M Bridge Loan maturity or secure favorable long-term alternative financing remains key.
Sustaining Growth Strategies Anticipated growth relies on effectively managing integration efforts and expanding client base organically and via M&A.
Target Market Determination Future success depends on ability to accurately determine target market size and achieve forecasted growth rates.
同業比較
売上高 (TTM)
$2.51B
$2.21B
$1.23B
粗利益率 (最新四半期)
84.0%
78.4%
77.6%
主要指標
銘柄コード | 時価総額 | PER (TTM) | ROE (TTM) | 負債比率 |
|---|---|---|---|---|
| TXG | $2.72B | -121.5 | -2.9% | 8.0% |
| NVCR | $2.02B | -11.5 | -50.8% | 29.8% |
| OMCL | $1.97B | 95.9 | 1.6% | 10.1% |
長期トレンド
直近4四半期
売上高
純利益
営業キャッシュフロー
4四半期売上高CAGR
3.1%
緩やかな成長
4四半期純利益CAGR
N/M
収益構造の変化
キャッシュフロー安定性
100%
優れたキャッシュフローの実績
深度リサーチ
次回決算:2026年5月26日
EPS:$0.10
|売上高:$135.27M
財務データ
決算説明会
財務レポート
ニュース
損益計算書
バランスシート
キャッシュフロー計算書
財務比率
変化率
損益計算書 | 直近12ヶ月 |
|---|
データなし